S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
Top Wellness Nasdaq Stock for 2023 (Ad)
Stock market today: Wall Street wraps its miserable September with another weak finish
PayPal Keeps Getting Cheaper; Should You Load Up?
As AI Explodes this Company Could Skyrocket (Ad)
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
Delta Hopes to Soar Again with Customer Loyalty Tweaks
As AI Explodes this Company Could Skyrocket (Ad)
Is the Grinch Stealing This Year's Holiday Season Jobs?
The Next Stage Of Google’s Rally Just Started
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
Top Wellness Nasdaq Stock for 2023 (Ad)
Stock market today: Wall Street wraps its miserable September with another weak finish
PayPal Keeps Getting Cheaper; Should You Load Up?
As AI Explodes this Company Could Skyrocket (Ad)
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
Delta Hopes to Soar Again with Customer Loyalty Tweaks
As AI Explodes this Company Could Skyrocket (Ad)
Is the Grinch Stealing This Year's Holiday Season Jobs?
The Next Stage Of Google’s Rally Just Started
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
Top Wellness Nasdaq Stock for 2023 (Ad)
Stock market today: Wall Street wraps its miserable September with another weak finish
PayPal Keeps Getting Cheaper; Should You Load Up?
As AI Explodes this Company Could Skyrocket (Ad)
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
Delta Hopes to Soar Again with Customer Loyalty Tweaks
As AI Explodes this Company Could Skyrocket (Ad)
Is the Grinch Stealing This Year's Holiday Season Jobs?
The Next Stage Of Google’s Rally Just Started
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
Top Wellness Nasdaq Stock for 2023 (Ad)
Stock market today: Wall Street wraps its miserable September with another weak finish
PayPal Keeps Getting Cheaper; Should You Load Up?
As AI Explodes this Company Could Skyrocket (Ad)
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
Delta Hopes to Soar Again with Customer Loyalty Tweaks
As AI Explodes this Company Could Skyrocket (Ad)
Is the Grinch Stealing This Year's Holiday Season Jobs?
The Next Stage Of Google’s Rally Just Started
NASDAQ:NERV

Minerva Neurosciences (NERV) SEC Filings & 10K Form

$6.90
-0.17 (-2.40%)
(As of 09/29/2023 ET)
Compare
Today's Range
$6.51
$7.20
50-Day Range
$7.07
$10.52
52-Week Range
$1.26
$14.70
Volume
26,692 shs
Average Volume
404,128 shs
Market Capitalization
$48.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.00

Recent Minerva Neurosciences SEC Filings

DateFilerForm TypeView
09/29/2023
7:57 AM
Laghrissi-Thode Fouzia (Reporting)
Minerva Neurosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
7:58 AM
Kupfer David (Reporting)
Minerva Neurosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
7:58 AM
HILLEMAN JERYL L (Reporting)
Minerva Neurosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
7:59 AM
Minerva Neurosciences (Issuer)
VAN HEEK G JAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
8:00 AM
HASLER HANS PETER (Reporting)
Minerva Neurosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
8:25 AM
Minerva Neurosciences (Filer)
Form DEF 14A
08/15/2023
8:26 AM
Minerva Neurosciences (Filer)
Form DEFA14A
08/15/2023
8:28 AM
Minerva Neurosciences (Filer)
Form ARS
08/09/2023
11:15 PM
Minerva Neurosciences (Filer)
Form EFFECT
08/04/2023
7:07 AM
Minerva Neurosciences (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/01/2023
6:01 AM
Minerva Neurosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/07/2023
3:18 PM
Boehringer AG (Filed by)
Minerva Neurosciences (Subject)
Form SC 13D
07/07/2023
3:15 PM
Boehringer AG (Reporting)
BOEHRINGER INGELHEIM INTERNATIONAL GMBH (Reporting)
Minerva Neurosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/03/2023
3:04 PM
Minerva Neurosciences (Filer)
Form D
Notice of Exempt Offering of Securities 
06/28/2023
7:37 AM
Minerva Neurosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2023
7:41 AM
Minerva Neurosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2023
6:01 AM
Minerva Neurosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/05/2023
3:18 PM
Minerva Neurosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2023
5:13 PM
Ahlholm Frederick W (Reporting)
Minerva Neurosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
5:14 PM
Minerva Neurosciences (Issuer)
Race Geoff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
5:15 PM
Luthringer Remy (Reporting)
Minerva Neurosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2023
6:18 AM
Minerva Neurosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2023
3:58 PM
Minerva Neurosciences (Filer)
Form 10-K/A
03/08/2023
5:30 AM
Minerva Neurosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/01/2023
10:16 AM
FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Minerva Neurosciences (Subject)
Form SC 13G/A
12/28/2022
7:24 AM
Minerva Neurosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2022
3:31 PM
Minerva Neurosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/14/2022
3:47 PM
Ahlholm Frederick W (Reporting)
Minerva Neurosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2022
3:48 PM
Minerva Neurosciences (Issuer)
Race Geoff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2022
3:50 PM
Luthringer Remy (Reporting)
Minerva Neurosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2022
6:00 AM
Minerva Neurosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/17/2022
7:37 AM
Minerva Neurosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:NERV) was last updated on 9/30/2023 by MarketBeat.com Staff

My Account -